- CH₣1.53bn
- CH₣1.60bn
- €391.95m
Brief: Polypeptide Group AG And Cytovance Biologics Announce Collaboration For Microbial And Mammalian-Expressed Peptide Drugs
Upgrade Of 2024 Full-Year Guidance
Brief: PolyPeptide Group H1 Revenue EUR 135.043 Million
Brief: Donaldson Company, Polypeptide Partner To Improve Sustainability In Peptide Manufacturing With Solvent Recovery Technology
Brief: Polypeptide Says Peter Wilden Was Re-Elected As Chair Of Board Of Directors
Brief: PolyPeptide Group FY EBITDA EUR -5.999 Million
Swiss stocks - Factors to watch on March 12
Brief: PolyPeptide Not To Propose Dividend To The Upcoming AGM
Brief: Polypeptide Signs Scientific Collaboration Agreement
Brief: Polypeptide Secures Revolving Credit Facility
Citigroup cuts Polypeptide to 'sell' as operational issues still drag profits
Europe Research Roundup: Bayer AG, Cab Payments Holdings, TT Electronics
Brief: Polypeptide Group H1 Revenue Of EUR 131.8 Mln
Europe Research Roundup: Bachem Holding AG, Pernod Ricard, Rio Tinto
Polypeptide Expects Net Loss For H1 And Full Year
Europe Research Roundup: Acciona Energia, Burberry Group, Relx
Citi initiates four European life sciences stocks
Brief: PolyPeptide and Numaferm announce partnership to leverage their expertise for the more sustainable production of peptide-based APIs
Brief: Polypeptide Appoints Juan-José Gonzalez As CEO And Announces Change Of CFO